Page 13 - AIH-1-1
P. 13
Artificial Intelligence in Health AI in prostate cancer detection
Table 2. Influential authors, countries, and affiliations
Top 20 productive Top 20 cited Top 20 productive Top 20 cited Top 20 affiliations
authors authors countries countries
Authors No. of Author LC Country No. of Country TC Affiliations No. of
articles documents articles
Madabhushi A 15 Xu J 29 USA 571 USA 4271 National Cancer Institute 21
Turkbey B 10 Fu Y 26 Canada 148 UK 806 Case Western Reserve University 19
Abolmaesumi P 7 Wang Y 21 China 132 China 625 Medical College Of Wisconsin 19
Kwak JT 7 Chareonthaitawee P 20 Germany 88 France 451 University Of California 14
Xu S 7 Clarke B 20 UK 83 Canada 389 German Cancer Research Center 13
(Dkfz)
Choyke PL 6 Drzezga A 20 Italy 53 Netherlands 327 Memorial Sloan Kettering Cancer 13
Center
Li M 6 Li M 20 France 45 Germany 245 Stanford University 12
Liu Y 6 Lindenberg L 20 South korea 43 India 192 University Health Network 12
Mousavi P 6 Madabhushi A 20 Sweden 39 Sweden 136 Sichuan University 11
Wang L 6 Rahmim A 20 Netherlands 34 Japan 100 University Of Turku 11
Yang X 6 Sunderland J 20 Spain 33 South Korea 98 University Of Toronto 10
Zhang Y 6 Thackeray J 20 Australia 32 Italy 77 Dalhousie University 9
Evans AJ 5 Ulaner GA 20 Norway 24 Turkey 61 National Institutes Of Health 9
Gao J 5 Wahl Rl 20 Turkey 24 Norway 58 University Of British Columbia 9
Iczkowski KA 5 Weber W 20 Finland 23 Switzerland 54 University Of Pennsylvania 9
Jambor I 5 Zukotynski K 20 India 20 Iran 53 Johns Hopkins University 8
Shen D 5 Wang X 18 Denmark 19 Ireland 47 Vanderbilt University 8
Wood B 5 Wang J 17 Belgium 16 Spain 43 Brigham And Women's Hospital 7
Algohary A 4 Feldman MD 16 Japan 15 Finland 40 Turku University Hospital 7
Choyke P 4 Fan X 15 Portugal 12 Hong Kong 38 University Medical Center 7
Groningen
Abbreviations: LC: Location citations; TC: Global citations.
Figure 3. Co-citation network.
especially in radiomics, is uniquely emphasized in citation ML-based analysis to improve diagnostic performance in
analysis. For instance, Wang et al. described the use of clinically relevant prostate cancer. In addition, Ginsburg
[31]
Volume 1 Issue 1 (2024) 7 https://doi.org/10.36922/aih.1958
